跳至主要内容
临床试验/NCT00284713
NCT00284713已完成1 期

Transplantation Of Progenitor Cells And Recovery Of Left Ventricular Function In Patients With Nonischemic Dilatative Cardiomyopathy

Johann Wolfgang Goethe University Hospital0 个研究点目标入组 30 人开始时间: 2004年5月1日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
30
主要终点
LV function (Ejection fraction within 3 months) Simpson

研究概览

简要总结

Intracoronary infusion of bone marrow derived progenitor cells into the LAD in patients with non ischemic dilated cardiomyopathy.

详细描述

Initial clinical pilot trials suggested that intracoronary infusion of bone marrow-derived progenitor cells (BMC) may enhance left ventricular functional recovery in patients with acute myocardial infarction. It is unknown, however, whether such a strategy might also be applicable to patients with non-ischemic dilated cardiomyopathy (DCM). Therefore, we initiated the TOPCARE-DCM - trial (Transplantation Of Progenitor Cells And Recovery of Left Ventricular Function in Patients with non ischemic Dilatative CardioMyopathy) aiming to regionally improve left ventricular contractility by selective infusion of BMC into the left anterior descending coronary artery.

Patients will be randomized 2:1 (20/10) BMC Infusion versus standard medical therapy

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Dilated Cardiomyopathy, Ejection fraction < 40%
  • LVEDD > 60mm
  • Stable clinical condition within last 6 months
  • Written informed consent

排除标准

  • Myocardial infarction or coronary intervention in the past
  • Change of medical therapy within the last 6 weeks prior to cell therapy
  • Tumor within last 5 years or incomplete remission
  • Active infection
  • Active bleeding
  • Stroke within last 2 years
  • Surgery or trauma within last 2 months
  • Uncontrolled hypertension
  • HIV infection
  • Chronic inflammatory disease
  • Liver disease (GOT > 2x upper normal limit)
  • Renal dysfunction (creatinin > 2.0mg/dl)
  • Thrombopenia < 100.000
  • Anemia (hemoglobin < 8.5 g/dl)
  • Mental retardation

结局指标

主要结局

LV function (Ejection fraction within 3 months) Simpson

时间窗: 4 months

次要结局

未报告次要终点

研究者

发起方
Johann Wolfgang Goethe University Hospital
申办方类型
Other

相似试验